Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.14 +0.02 (+1.79%)
As of: Oct 1, 2026 · 3:57 PM EDT

Actinium Pharmaceuticals (ATNM) Other Non-Current Assets (2014 - 2026)

Updated

Actinium Pharmaceuticals' Other Non-Current Assets was $339,000 in Q2 2026, up 3.0% from $329,000 a year earlier and up 0.6% from the prior quarter.

Analysis

Actinium Pharmaceuticals (ATNM) Other Non-Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Actinium Pharmaceuticals came in at $335,000, up 3.4% from FY2024.

  • Other Non-Current Assets has now increased for four consecutive years, though with a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Assets was $324,000 in FY2024 (+3.5%), $313,000 in FY2023 (+3.6%), $302,000 in FY2022 (+504.0%) and $50,000 in FY2021 (-87.2%).
  • The Q2 2026 figure marks the highest quarterly Other Non-Current Assets since Q3 2021.
  • Compared with a year earlier, Other Non-Current Assets has increased for 15 straight quarters, with growth averaging 3.4% over the last eight quarters.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q1 2023 (growth of 508.0%); the worst was Q1 2022 (a decline of 87.2%).
  • Per Business Quant data, ATNM's Other Non-Current Assets in the three quarters before Q2 2026 was $337,000 (Q1 2026), $335,000 (Q4 2025) and $332,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Actinium Pharmaceuticals 36.16 Mn 36.16 Mn - 339,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 339,000.00
Mar 31, 2026 337,000.00
Dec 31, 2025 335,000.00
Sep 30, 2025 332,000.00
Jun 30, 2025 329,000.00
Mar 31, 2025 327,000.00
Dec 31, 2024 324,000.00
Sep 30, 2024 322,000.00
Jun 30, 2024 318,000.00
Mar 31, 2024 316,000.00
Dec 31, 2023 313,000.00
Sep 30, 2023 310,000.00
Jun 30, 2023 307,000.00
Mar 31, 2023 304,000.00
Dec 31, 2022 302,000.00
Sep 30, 2022 300,000.00
Jun 30, 2022 299,000.00
Mar 31, 2022 50,000.00
Dec 31, 2021 50,000.00
Sep 30, 2021 392,000.00
API Access

Actinium Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ATNM&period=max&api_key=YOUR_API_KEY